26 Emobilya Building , sherif basha street, Downtown , cairo , egypt
Head office phone number
Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4
Impact of coronavirus on African Economy
Covid-19 in Africa
Africa Joint Continental Strategy for COVID-19 OUTBREAK
A village without hepatitis C in Egypt: will micro-elimination lead to macro-elimination?
Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial